Format

Send to

Choose Destination
See comment in PubMed Commons below
Allergy. 2009 Jan;64(1):158-65. doi: 10.1111/j.1398-9995.2008.01813.x.

Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.

Collaborators (145)

Hamans EP, Cauwenberge Pv, Belder Td, Sys L, Schmelzer AA, van Vliet J, Van-nieuwenhuyse P, D'Hont G, Jorissen MB, Gevers G, Mandazhieva-Pepelanova MA, Slavov SP, Georgieva N, Kissiova KP, Odzhakova CH, Peneva MT, Karchev T, Mojanov O, Ivanov T, Benchev RY, Alexieva MN, Zhelyazkova ZZ, Fouquert L, Wessel F, Dubreil Y, Huet S, Ortolan D, Lukat KF, Lange B, Stuhmann NC, Decot E, Pasch N, Mereurs G, Hörmann K, Baisch A, Klimek L, Hansen I, Gene S, Malzahn K, Spielhaupter M, Kaczmarek J, Marciniak MB, Nowacki Z, Otto-Markiewicz A, Markiewicz J, Caban V, Skucha W, Janicka J, Szadkowska-Bach M, Cichon-Szyperko L, Wawszczyk E, Lukasiewicz-Swierczynska B, Nalepa P, Straczek C, Kommata K, Pajor A, Kucia A, Sibila W, Pinis G, Dyczek A, Adamek-Guzik T, Mysik-Czerniawska G, Prochowska K, Guzik T, Markiewicz-Bendkowska I, Iwko J, Juszczak EA, Nowakowski M, Wieckowska E, Madaj A, Tavares NB, Loureiro GM, Morais MA, Gaspar AP, Pires MG, Fernandes J, Leiria P, Vaz MG, Coimbra A, Moreira A, Oliveira F, Bradu I, Popa-Velea O, Bumbacea RS, Samuila S, Iacomi A, Radu C, Grigore R, Zainea V, Negrila M, Pinto E, Roger A, Dordal T, Viñas M, Vidal C, Rodríguez V, Armasen M, Gastaminza G, Audicana MT, Fernández E, Muñoz D, Bernedo N, Echenagusia MA, Aragón R, Prados M, Basomba A, Almero R, Campos A, Giner A, Sastre J, Lluch M, Novalbos AP, Pérez R, Carretero P, García F, Juste S, Fernández-Rivas M, Alonso MD, González E, Rosado A, Vila C, Tejedor M, Martí E, Pau L, Dávila I, Laffond E, Moreno E, Cadahía A, Cardona V, Guillarte M, Gonzalo MA, Pérez R, González C, García MM, Varela S, Conde J, Conde A, Hernández M, Guerra F, Justicia JL, Barahona MJ, Martínez-Cócera C, Agustín MP, Reig I, Vázquez L.

Author information

1
Department of Oto-Rhino-Laryngology, Ghent University Hospital, Ghent, Belgium.

Abstract

BACKGROUND:

Bilastine is a novel, nonsedating H(1)-antihistamine developed for symptomatic treatment of Allergic Rhinitis and Chronic Idiopathic Urticaria. The objective of this study was to compare the efficacy and safety of bilastine 20 mg vs placebo and desloratadine 5 mg in subjects with seasonal allergic rhinitis (SAR).

METHODS:

This randomized, double blind, placebo-controlled, parallel-group multicentre study evaluated the effect of 2 weeks' treatment with bilastine 20 mg, desloratadine 5 mg or matched placebo once daily, in 12-70 years old symptomatic SAR patients. All subjects assessed the severity of nasal (obstruction, rhinorrhoea, itching, and sneezing) and nonnasal (ocular itching, tearing, ocular redness, itching of ears and/or palate) symptoms on a predetermined scale to provide a total symptom score (TSS), composed of nasal and nonnasal symptom scores (NSS and NNSS, respectively). The primary efficacy measure was the area under the curve (AUC) for the TSS over the entire treatment period.

RESULTS:

Bilastine 20 mg significantly reduced the AUC of TSS to a greater degree from baseline compared to placebo (98.4 with bilastine vs 118.4 with placebo; P < 0.001), but not compared to desloratadine 5 mg (100.5). Bilastine 20 mg was not different from desloratadine 5 mg but significantly more effective than placebo in improving the NSS, NNSS, and rhinitis-associated discomfort scores (P < 0.05), and rhinoconjunctivitis quality of life questionnaire total (P < 0.005) and four out of seven individual domain (P < 0.05) scores. The incidence of treatment emergent adverse events was similar for bilastine (20.6%), desloratadine (19.8%), and placebo (18.8%).

CONCLUSION:

Bilastine 20 mg once daily was efficacious, safe and not different from desloratadine 5 mg once daily in the treatment of SAR symptoms.

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center